![]() |
|||

Caffine
Parkison Disease
2007/4/19/5
J Immunol. 2006 Nov 15;177(10):7173-83. IL-1beta and TNF-alpha
regulation of the adenosine receptor (A2A) expression: differential
requirement for NF-kappaB binding to the proximal
promoter. ·
Morello
S, Ito K, Yamamura S,
Lee KY, Jazrawi
E, Desouza
P, Barnes P, Cicala
C, Adcock IM.
Airways Disease Section, Adenosine is a potent endogenous regulator of airway
inflammation that acts through specific receptor subtypes that can either
cause constriction (A1R, A2BR, and A3R) or relaxation (A2AR) of the
airways. We therefore examined the effects of key inflammatory mediators on
the expression of the A2AR in a lung epithelial cell line (A549). IL-1beta
and TNF-alpha increased the expression of the A2AR gene at the mRNA and
protein levels. In contrast, LPS had no effect on A2AR gene expression.
IL-1beta and TNF-alpha rapidly activated p50 and p65, but not C-Rel, RelB, or p52, and both
IL-1beta- and TNF-alpha-stimulated A2AR expression was inhibited by the IkappaB kinase 2 inhibitor AS602868 in a concentration-dependent
manner. Using chromatin immunoprecipitation
assays, we demonstrate that IL-1beta can enhance p65 association with
putative kappaB binding sites in the A2AR
promoter in a temporal manner. In contrast, TNF-alpha failed to enhance p65
binding to these putative sites. Functionally, the two most 5' kappaB sites were important for IL-1beta-, but not
TNF-alpha-, induced A2AR promoter reporter gene activity. Finally, neither
TNF-alpha nor Il-1beta had any effect on A2AR mRNA transcript degradation.
These results directly implicate a major role for NF-kappaB
in the regulation of A2AR gene transcription by IL-1beta and TNF-alpha but
suggest that the effects of TNF-alpha on A2AR gene transcription are not
mediated through the proximal promoter. PMID: 17082635 [PubMed - in
process] Mol Biol Cell. 2006 Oct 25; [Epub
ahead of print] Synergistic Up-Regulation
of Vascular Endothelial Growth Factor (VEGF) Expression in Macrophages by
Adenosine A2A Receptor Agonists and Endotoxin
Involves Transcriptional Regulation via the Hypoxia Response Element (HRE)
in the VEGF Promoter. ·
Ramanathan
M, Pinhal-Enfield
G, Hao
I, Leibovich
SJ. Department of Cell Biology and Molecular
Medicine and The Cardiovascular Research Institute, New Jersey Medical
School, University of Medicine and Dentistry of New Jersey (UMDNJ), Newark,
NJ 07103. Monitoring Editor: Richard Assoian Macrophages are an important source of VEGF. Adenosine A2A receptor (A2AR)
agonists with Toll-like receptor (TLR) 2, 4, 7, and 9 agonists
synergistically induce macrophage VEGF expression. We show here using VEGF
promoter-luciferase reporter constructs that the
TLR4 agonist Escherichia coli LPS and the A2AR agonists NECA and CGS21680
synergistically augment VEGF transcription in macrophages, and that the HRE
in the VEGF promoter is essential for this transcription. We examined
whether LPS and/or NECA induce HIF-1alpha expression. HIF-1alpha mRNA
levels were increased in LPS-treated macrophages in an NF-kappaB-dependent manner; NECA strongly increased these
levels in an A2AR-dependent manner. LPS induced luciferase
expression from a HIF-1alpha promoter-luciferase
construct in an A2AR-independent manner. Further stimulation with NECA did
not increase HIF-1alpha promoter activity, indicating that the
A2AR-dependent increase in HIF-1alpha mRNA is post-transcriptional.
LPS/NECA treatment also increased HIF-1alpha protein and DNA binding
levels. Deletion of putative NF-kappaB-binding
sites from the VEGF promoter did not affect LPS/NECA-induced VEGF promoter
activity, suggesting that NF-kappaB is not
directly involved in VEGF transcription. Taken together, these data
indicate that LPS/NECA-induced VEGF expression involves transcriptional
regulation of the VEGF promoter by HIF-1alpha through the HRE. HIF-1alpha
is transcriptionally induced by LPS, and post-transcriptionally up-regulated in an A2AR-dependent
manner. PMID: 17065555 [PubMed - as
supplied by publisher